VDAC1 and cancer: Gene expression meta-analysis also identifies VDAC1 as a predictor of poor outcome in early stage non-small cell lung cancer, and silencing VDAC1 expression by siRNA has been shown to inhibit cancer cell proliferation and tumor growth [26, 27, 29].